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The Treatment of Puerperal Streptococcal Sepsis
By H. F. S. LINDSAY, M.B., B.CH.
from the Belfast Union Infirmary
DURING my residence at Belfast Infirmary I was entrusted with the immediate
charge of the isolation department for the reception and treatment of patients
suffering from puerperal septic infection. This privilege enabled me to investigate
the identity of the causative organism in each case admitted. In the great majority
I found this organism to be the streptococcus haemolyticus, isolated from the body
of the uterus. Whilst at hospital I embraced the opportunity of estimating the
relative values of several forms of treatment, and this paper is in the nature of a
report of the results obtained. In addition to general measures, I shall endeavour
to discuss these treatments under the headings of "Local Treatment," "Drugs,"
"Vaccine Therapy," and "Serum Therapy" respectively.
General measures include absolute rest in bed, the cleanliness and comfort of the
patient (including the provision of air-cushions), regularity in the movements of
the bowels, a generous fluid intake, and plenty of fresh air. Hydrotherapeutic
measures are very valuable in the control of fever. The diet should be richly
nutritive and easily digestible. Lastly, the patient should be kept as cheerful as
possible.
LOCAL TREATMENT.
INTRA-UTERINE INJECTIONS OF STERILE GLYCERINE.
(a) PROPHYLAXIS.-I have found the above method of particular value as a prophy-
lactic measure in suspicious cases. The healing properties of glycerine are widely
appreciated; and, when following labour, the raw inner surface of the uterus is
treated with sterile glycerine, it recovers its normal healthy condition much more
readily.
(b) CURATIVE.-Here the glycerine treatment, in order to be of real value, must
be employed very early in the disease. Glycerine, as a local method of treatment,
is applicable to local infections. By promoting a free flow of lymph from the uterine
wall into the uterine cavity, it produces a "lavage a retro," by which infecting
bacteria are washed away; and the lymph possesses bactericidal properties. In a
virulent infection, such as that associated with the streptococcus haemolyticus, the
local defence may well be overcome before local measures can be afforded a proper
chance, and hence the glycerine treatment would not be advised in such cases as an
exclusive method of treatment.
TREATMENT BY DRUGS.
Drugs having reputed bactericidal action are numerous, but experience does not,
even when the chemical agent is exploited generously and by the intravenous route,
justify any degree of confidence in them.
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from a belief in its antiseptic action in the blood. In this connection it has to be
remarked that the microbes of septic fever are much more resistant to the action of
quinine outside the body than are the protozoa, and the question therefore arises
whether the blood and tissues are not liable to be seriously injured by the-quantity
of quinine required to act upon the parasites they contain. Sir William Whitla says
of quinine that "one grain in four ounces will destroy the white corpuscles of fresh
human blood." Dr. Cushny points out that in many cases of septicaemia, where
successful results have been claimed from quinine, the dose was far too small to be
capable of acting either on the temperature or on the microbe. He also mentions
that the reputed action of quinine in retarding tissue waste has now been proved to
be erroneous.
At Belfast Infirmary we gave quinine an extensive trial as a bactericide in early
cases of puerperal streptococcal septicaemia. The results were disappointing, and
did not at all encourage us to advocate quinine as an exclusive method of treatment
in this disease. We formed the opinion that this drug, even when administered in
large therapeutic doses and regularly repeated during the twenty-four hours, is not
a sufficiently strong therapeutic agent to overcome virulent haemolytic streptococci
in the blood-stream, where, it should be added, their powers of speedy multiplication
and toxin elaboration are only too well known. Since we have already seen that
massive doses cannot be recommended because of the serious risks involved, there
is little use in persevering with this remedy as a curative measure in puerperal
streptococcal septicmmia.
As a p,rophylactic in suspicious cases, some authorities recommend quinine grs. 7i
with anti-streptococcal serum (20 c.c.).
(b) COLLOIDAL SILVER.-The employment of this drug is based upon its antiseptic
properties. It is administered by the intramuscular route, and it represents one of
the modern methods of treatment in puerperal streptococcal infection. Sir Thomas
Horder states that it has yielded "some apparent good results," but he considers
it as still on probation.
We have used this drug at Belfast Infirmary, but the results we obtained were
not sufficiently convincing to justify my advocating it here as a general method
of treatment. At the same time, there are some cases in which it seems to do good.
(C) SALTS OF MERCURY.-.The perchloride and salicylate and mercurochrome have
been recommended, but the published results did not encourage us to give them a
trial. For the same reason we did not use Flavine, Eusol, or arsenical compounds.
VACCINE THERAPY.
Vaccines are spoken of as belonging to either the "stock" or the "autogenous"
variety. Of the former variety Sir Thomas Horder writes: "There are certain
circumstances in which the use of stock vaccines is not only justified, but obligatory,
e.g., in most instances where the vaccine is used for prophylactic purposes.
(a) PROPHYLAXIS.-At Belfast Infirmary we found the use of an appropriate
stock vaccine of great assistance in reducing the incidence of puerperal strepto-
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purpose was 5,000,000 cocci to 1 c.c., and the initial dose was one minim, followed,
after five days, by a final dose of two minims. Of fifty-two patients treated in this
way only one subsequently developed puerperal pyrexia.
(b) CURATIVE.-If it is decided to employ a vaccine in puerperal streptococcal
sepsis, an autogenous one is to be preferred to a stock. This, of course, involves
the disadvantage of having to wait until it is made. Thus, assuming that the nature
of the infection is definitely established, it may be advisable to employ a vaccine
of a kind known to correspond with the infection but made from another source,
pending the arrival of the autogenous vaccine.
At Belfast Infirmary we gave autogenous vaccines an extensive trial in the
treatment of puerperal streptococcal septic infection, but the results were very
disappointing. Considering that the toxin with which we are dealing here belongs
to the exogenous variety, and comparing the results which I have seen from early
antitoxic serum administration, with those from early vaccine therapy, I have been
led to the conclusion that the latter method is much less uniformly successful in
the treatment of this disease.
Dr. Bigger, in his "Handbook of Bacteriology," writes: "Vaccines are of less
utility in the treatment of acute streptococcal diseases than are sera. Many
authorities are of opinion, however, that in certaini conditions, particularly in
puerperal sepsis, vaccine therapy occasionally produces remarkably good results.
I may add that I have found vaccines of undoubted value in puerperal staphy-
lococcal infection. In this connection Sir Thomas Horder and Dr. John Matthews
write: "The immune treatment of staphylococcus infections is entirely by vaccine.
This is due to two reasons : Vaccines have been more successful in these infections
than in any others; and no staphylococcal serum of any potency in bactericidal
substances has as yet been produced."
SERUM THERAPY.
There are two kinds of sera, namely, antibacterial and antitoxic.
(a) ANTIBACTERIAL SERA.-These are subdivided into two classes-polyvalent and
univalent. In deciding as to the value of an appropriate antibacterial serum in the
treatment of puerperal streptococcal septicaemia, we have not only to examine into
the nature of the serum used, but also into that of the septicaemia. First of all, the
toxins produced by haemolytic streptococci are, as we have already seen, of the
exogenous variety, and hence may be absorbed into the circulation apart from the
streptococci which elaborate them, thus giving rise to the conditioni of exotoxwmia.
Now, in puerperal streptococcal infection, a dose of anti-streptococcal serum will
only be accessible to the infectinig streptococci when they succeed in entering the
blood-stream. By the time this occurs, however, there will frequently be encountered
a well-marked exotoxaemia. In this connection it is important to remember that
exotoxins in the circulation are little affected by an antibacterial serum; and the
only type of serum by which thev can successfully be neutralized is a suitable
antitoxic one, a(dministered at the proper time. Hence, we can expect little from
90an anti-streptococcal serum in the matter of neutralizinig the exotoxins produced in
puerperal streptococcal sepsis. lhe most we can expect from such an antibacterial
serum is a destructioni of the organisms against which it is prepared, this action
depending upon two conditions, namely, its degree of potency as an appropriate
bactericidc, an(l the day of illness upon which the trcatment commences. Assuminig
that the latter is sufficienitly early to give the serum a fair chance, then the success
of the treatment will (lepend upon its bactericidal power. That is to say, the potency
of such a serum as a bactericide will then measure its value as a method of treat-
ment. Actually, what is this value? Sir Thomas Horder and Dr. John Matthews,
referring to antibacterial sera generally, write: "By none of the metho(ds yet
employed have these sera been producedl with a sufficicnitly rich contelnt of antibody
to lead to any uniformly good results."
POLYVALENT SERA. -Streptococci generally, as we know, exist in groups, and anl
anti-streptococcal serum preparedl against onic group is not by any means specific
in respect of antibody for another group. It was therefore with the express object
of overcoming this difficulty that a polyvalent anti-streptococcal serum was pro-
duced, the idea being that no matter to what group the infecting streptococc;
belonged-hlemolytic or otherwise-it would be met by the polyvalent serum. The
attempt, however, as Sir Thomas Horder tells us, "has not proved successful."
At Belfast Infirmary we gave polyvalent anti-streptococcal serum a very fair and
extensive trial, anid I regret to say that the results obtained were very disappointing,
the dceath-rate being little affected. It has to be remembered that only one group of
streptococci is involved in the particular form of puerperal sepsis under considera-
tion, namely, the hawmolytic group-the most virulent group of all. So, when we
use a polyvalent serum in the treatment of this disease, we are using one of whose
potency only a certain proportion is directed against the streptococcal group con-
cerned. For this reason, in addition to those already given, I am not disposed to
advocate the employment of such a serum as an effective method of treatment in
puerperal streptococcal sepsis.
UNIVALENT SERA.-In comparison with the last type, a univalent streptococcus
haemolyticus serum is much to be preferred, because it is concentrated against one
particular group of streptococci, and that the one involved in puerperal streptococcal
septicaemia. Sir Thomas Horder observes that in the case of streptococcal infections
a univalent streptococcus pyogenes serum has been available for some years as the
result of suggestions put forward by Andrewes and Horder. We have always to
remember, however, that, at the best, a concentrated, univalent, streptococcus
haemolyticus serum is an antibacterial one, and as such is not prepared to neutralize
exotoxins, the variety predominating in puerperal streptococcal sepsis.
(b) ANTITOXIN SERA.-I have found anti-scarlatinal serum an excellent antitoxin
serum in the treatment of puerperal streptococcal sepsis. To a series of twenty-two
cases at the Belfast Infirmary, whose intra-uterine swabs each demonstrated the
presence of haemolytic streptococci, we administered anti-scarlatinal serum with
remarkably good results, which I tabulate at the end of this section.
And why, we ask, should anti-scarlatinal serum effect these results? Because
the aetiological streptococcus in puerperal streptococcal septicaemia and scarlet fever
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an identical toxin, the Dick toxin. Hence, a serum successful in neutralizing the
toxin of scarlatina must necessarily have a similar effect upon the toxin produced
in puerperal streptococcal sepsis.
How Prepared.-Based on the work of the Dicks relative to the zetiological
relationship of a certain type of the streptcoccus hwamolyticus to scarlet fever, this
antitoxin is prepared as follows: Horses are inoculated with gradually increasing
doses of toxin obtained from cultures of streptococci recently isolated from patients
suffering from scarlatina in a severe form, and in due time bled (1) (2) (3). The
active serum protein, separated from the other serum constituents, possesses high
antitoxic properties, its potency being determined by the hygienic laboratory,
Washington, U.S.A.
Clinical Uses.-(a) Prophylactic in scarlatina.
(b) Curative-scarlatina.
(c) Prophylactic in puerperal sepsis (streptococcus haemolyticus).
(d) Curative early puerperal sepsis (streptococcus haemolyticus).
Action.-Anti-scarlatinal serum, as an antitoxin, acts chiefly by neutralizing
exotoxins formed by hwmolytic streptococci in the body.
I'hleories of Action.-In an article written by Sir Thomas Horder and Dr. J.
Matthews wve read: "Antitoxin sera procluce their effects by simple combination
with, and neutralizationi of, the toxins eliciting them, in wvhich their action differs
from that of opsonins and agglutinins, in both of which instances visible and
nmcasurable effects are observable. Much discussion has occurred as to the nature
of their utnion. Ehrlich maintainied there was firm chemical union; Arrhenius and
Madsen considere(d the union similar to that of two substances in xveak chemical
union, a unlioin to some extent reversible; while Bordat considered it a physical
process, the smaller molecule of toxin becoming, as it were, entangled in the larger
molecule of antitoxin. Tlhe union has a time factor, as shown by an experiment of
Martin aind Cherry, wlho forced toxin and antitoxin through filters under high
pressure. At first all the toxin passed through, but after tw^o hoturs no toxin passed,
as it was held back by union ivith the antitoxin. A great deal of work has also been
(lone in coninectioni with the question of the composition of toxin, but it must suffice
to say that toxin represents more than onie poisonous substance and that the
proportionis vary in (lifferent samples. Similarly, the composition of antitoxin has
been the subject of much discussiot. That antitoxin is not merely altere(d toxin is
certain in that antitoxin may be obtained in anl amount many times greater than
that of the toxini inijectedl.
PROPHYLACTIC ADMIN ISTRATION.
1. Indications.-(a) Marked general debility.
(b) Septic focus or foci.
(c) After manipulative interference, e.g., bipolar podalic version.
2. Dosage.-5 c.c. In somne cases, however, up to 10 c.c. may be considered
necessary for safety.
923. Aniaphylactic Precautions.-Before administering a dose of antitoxin, whether
as a prophylactic or a curative measure, it is of the greatest importance to ascertain
whether or not the patient requires to be desensitized, and to act accordingly. Thus,
in patients giving a history of one or other of the specific fevers, or, apart from the
latter, of having had a previous dose of serum at an interval of ten or more days,
the following skin test should be carried out: "A small quantity, say 0.25 c.c., of
normal horse serum (or antitoxin) is injected intradermally or rubbed into a scarified
surface. There occurs, if anaphylaxis-or a toxic idiopathy to horse substance-
exist, an urticurial patch sometimes progressing to a vesicular eruption with a
surrounding area of erythema. This occurs usually within half an hour, but is
occasionally delayed. If anaphylaxis be demonstrated, the patient should be
desensitized. "
4. Mode of Administration.-Intramuscularly and very slowly.
5. Best Time to Administer.-Immediately after third stage of labour. In the
presence of a septic focus, for example, an immediate dose will assist in neutra-
lizing toxins that are being absorbed therefrom, and will reinforce the system's
defence at a time when the patient's resistance is frequently diminished.
6. Prophylactic Cases.-The following cases, with the addition of one other,
represent all those with whom I have tried anti-scarlatinal serum as a prophylactic
measure. They seemed to me to be candidates for puerperal sepsis, which, after
serum administration, did not develop in any of them.
(a) Macerated hydrocephalic monster. Faetus very foul-smelling, followed by
decomposed placenta. Prophylactic dose of anti-scarlatinal serum was given
immediately after third stage. Subsequently there occurred no elevation in tempera-
ture or other manifestation of septic infection.
(b) Case harbouring the following lesions :-Pyorrhoea alveolaris, glossitis,
stomatitis, and tonsillitis. Confinement normal (L.O.A.). Prophylactic dose of
anti-scarlatinal serum immediately after third stage. Subsequently there occurred
no elevation in temperature or other manifestation of sepsis.
(c) Manipulative case. L.O.A. Delivery complicated by double twist of umbilical
cord around the child's neck. Quick manipulation demanded to effect release. Third
stage complicated by retention of a large portion of chorion, necessitating manual
removal. Intra-uterine douche given. Prophylactic dose anti-scarlatinal serum
immediately afterwards. No subsequent pyrexia or signs of sepsis.
(d) Manipulative case: placenta prwevia. Os dilated two finger-breadths. Bipolar
podalic version carried out and foot brought down. Foetus subsequently delivered.
Intra-uterine douche given. Prophylactic dose anti-scarlatinal serum administered
immediately after third stage. Except for slight reactionary temperature of 99°F
on first evening, nothing abnormal ensued.
(e) Manipulative case. (Transverse presentation with hand and foot presenting.)
Considerable manipulation required to carry out a bipolar podalic version. Prophy-
lactic dose of anti-scarlatinal serum given immediately after third stage. On the
first three evenings following, the respective temperatures read: 1000F, 99.6°F,
and 99°F. Subsequently there were no signs of any description appertaining to
sepsis
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SEPTICA2MIA.
1. Dosage.-(a) Early cases, 10 c.c.
(b) Very severe early cases and more advanced cases, 20 c.c.
2. Route of Administration.-Intramuscularly and very slowly.
3. Best Time to Admninister.-As soon as the temperature and pulse have either
remained elevated at or above 99°F and 90 respectively for a period of twelve hours,
or have recurred after an interval of twenty-fours hours from their initial rise.
Reason: Because it is at this stage of the disease that anti-scarlatinal serum will be
found most effective in neutralizing the toxins elaborated by the infecting strepto-
cocci. The consequences of such early neutralization are of very great importance
to the patient concerned, and include the preservation from irreparable damage of
the cardiac muscle and other tissues for which the streptococcus haemolyticus has a
special affinity. Hence the work of the leucocytes in augmentinig the local resistance
and ingesting streptococci which may be encountered in the circulation is not being
undermined by an exogenous poisoning of the vital body tissues.
4. When to Repeat.-Twelve hours after the first injection, if the pulse and
temperature have not shown an appreciable diminution.
5. Anaphylactic Precauttions.-Ill my experienlce it is most decidedly the exceptioni
for a patient to require a dose of anti-scarlatinal serum at so great an interval as
ten days from the date of the first injection, if the latter has been administered
reasonably early in the disease. Such an exception would necessitate due observance
of the anaphylactic precautions discussed under "prophylactic administration." It
has been pointed out in the "British Medical Journal" that anaphylactic shock may
occur with a third dose of serum, if administered after an interval of more than ten
days from the date of the initial dose.
6. TVhen anti-scairlatinal serutm is too late to yield s(atisfactory resallts: When
hoemolytic streptococci can be grown oln culture from the patient's blood. It has
already been pointed out that if the few cubic centimetres of bloodl required for
culture demonstrate the presence of ha,molytic streptococci, how great must be
the magnitude of the general septicimia present. At this stage the streptococci
multiply at an alarming pace in the circulation and elaborate their toxins freely.
Consequently, the phagocytic value of the leucocytes, in which the polymorphs
figure prominently, becomes negatived by the steadily increasing army of hoemolytic
streptococci.
In short, the main reasons why the antitoxic agent fails at this late stage are two
in number:
(a) The blood-stream is being so drenched withl toxins that neutralization of them
is impracticable.
(b) Even if such neutralization were possible, the deadly toxic effects upon the
tissues have already imprinted themselves upon the unfortunate patient.
7. Arguments Concerning the Value of Anti-Scarlatinal Serum Treatmenlt.-
I was once asked the following question: "In a case of puerperal infection by the
streptococcus haemolyticus, what evidenice is available to show that the good
96results attributed to an early dose of anti-scarlatinal serum are really due to the
serum administered, and how may we know that such results would not have
occurred apart from any treatment, since there are cases on record where recovery
has taken place 'naturally'?" Now, in the foregoing question, there is implied the
fact that in certain patients' blood there is present a sufficient quantity of strepto-
coccal antitoxin to neutralize exotoxins produced by hxmolytic streptococci-an
implication which indicates the great importance of such antitoxin as an antagonist
to puerperal streptococcal sepsis. It is here that the importance of anti-scarlatinal
serum comes in, for since it is a streptococcus haemolyticus antitoxin itself, its
administration will serve either to compensate for antitoxin deficiency in the patient
concerned, or, should antitoxin be already present in any quantity, to augment it.
The more antitoxin, the less toxaemia.
Now, to show that an early dose of anti-scarlatinal serum is responsibe for the
good results attributed to it, one has only to compare the "pre-serum" condition
of a patient who is injected early in the disease with the "post-serum" condition.
To begin with, if the illness is at all severe, it is very improbable that the quantity
of streptococcal antitoxin present in the blood is great, and if the condition of the
patient twenty-four hours after serum administration shows a definite and generally
progressive change for the better, I do not think it is claiming too much to say that
the serum administered deserves the credit. This claim is further enhanced with a
negative history of scarlatina.
Again, in my experience individual prognosis in puerperal streptococcal sepsis is
often extremely difficult where anti-scarlatinal serum has not been administered
reasonably early. Statistics form the most reliable guide, and from my own on
next page it will be seen how greatly diminished was the death-rate, with anti-
scarlatinal serum treatment, among patients suffering from puerperal septic infection
(streptococcus haemolyticus) at Belfast Infirmary during the year 1930, the first
complete year in which we tried the antitoxin in question. Hence, in view of the
beneficial action of this serum as a neutralizer of haemolytic streptococcus exotoxins,
and in view of the marked reduction that I have seen in the number of deaths from
puerperal streptococcal sepsis with this serum, I can honestly recommend it as a
most valuable method of treatment and well worthy of our perseverance.
One point remains to be emphasized. Anti-scarlatinal serum, to be really effective,
must be administered early in the disease. It is lamentable to hear, as I have done,
an indifferent opinion expressed upon its worth on the basis of results obtained from
fourth- and fifth-day administrations. Failure in such instances is due to lateness
and not incompetency. What would be the results with anti-diphtheritic serum if it
were employed as late in diphtheria? The death-rate in that disease would certainly
not remain at its present level. Hence, since diphtheria, where the toxin alone enters
the blood-stream, merits due respect by early serum administration, should not
puerperal (haemolytic) streptococcal sepsis merit equal respect when we know that
the infecting organisms are themselves very likely to invade the circulation in
addition to their toxins, and rapidly multiply therein, if treatment is not commenced
in time?
97I should like to emphasize the fact that a negative blood-culture does not in itself
exclude a diagnosis of septiceemia. Very frequently a positive result indicates an
advanced stage of the disease, when little can be expected from any form of treat-
ment.
In conclusion, I wish to make it clear that I do not claim that anti-scarlatinal
serum constitutes a specific for the disease under consideration. What I do claim
is that it represents by far the most effective method of treatment which we have at
our disposal to-day.
STATISTICS.
During the year 1930, the total number of cases (intern and extern) admitted to
the isolation department for puerperal septic cases was twenty-seven. Of these,
twenty-two had haemolytic streptococci present in the intra-uterine swab, plus the
accompaniments of streptococcal infection. In some cases the latter were more
marked than in others, but in all they were quite definite. The death-rate among
these cases, all of which received the anti-scarlatinal serum treatment, was only
4.54 per cent., or 1 out of 22. Since one other streptococcal case, excessively
virulent, admitted before the beginning of the year, died, the total death-rate
among puerperal hamolytic streptococcal cases for the year 1930 stands at the
small percentage of 8.7 (to the nearest decimal point), or 2 out of 23. The large
majority of the cases received the serum in good time, which is mainly responsible
for the fact that only seven of them required a repeat dose.
Some Problems of the Panel Practitioner
By JAMES BOYD, M.A., M.D., B.SC., D.P.H.
Chief Medical Officer, Ministry ofLabour, N. 1.
MEDICAL benefit in Northern Ireland has now entered on its third year, and, in spite
of the gloomy prophecies of some of the pessimists both in and out of the profes-
sion, there would now appear to be almost a consensus of opinion that the scheme
represents a distinct advance in our medical services, both from the point of view of
the patients and that of the practitioners.
SCOPE OF SERVICE.-Stated briefly, it is a general practitioner service, but
insurance practitioners may, if they can show that they possess special skill and
experience, carry out and charge for certain services usually undertaken only by
specialists. In this connection it should be remembered that the following declara-
tion has to be made: "I have so informed the insured person, who has agreed that
I should render the service as a matter of special arrangement. " It is hardly
necessary to add that no part of the medical fund is available for specialist services.
If an operation is performed as an emergency, it does not follow that you are
entitled to regard the service as being "outside the scope."
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